Monthly Archives - July 2021

Wall St wobbles on Fed Chair testimony, inflation tug-of-war continues, Afterpay’s price target gets slashed: ASX to fall

15 Jul 2021 - Global markets took a step back to digest the state of affairs on inflation. U.S. shares closed mixed as the Federal Reserve chair testified before a House finance committee. Inflation blues hits Europe. I also cover how Apple Pay in 4 work & why Goldman Sachs involved. Macquarie drops target price rating for Afterpay (ASX:APT).

Read more...

Wall St hits new high ahead of earnings season, Why Challenger is a buy again: ASX to rise

13 Jul 2021 - Major global indexes started on a positive foot on Monday. US stocks edged higher ahead of earnings season. President Joe Biden calls for 80% of U.S. power to come from green energy. Richard Branson’s Virgin Galactic plummeted on news they will issue US$500 million of shares. Stockwatch today covers why Challenger (ASX:CGF) is a buy again with chart analysis as rated by Sequoia.

Read more...

Wall St post record highs, Why Rio Tinto is a buy: ASX to rise

12 Jul 2021 - In this report, I cover how global stocks staged a comeback on Friday as investors shrugged off concerns about the economic recovery. Market participants rushed to buy back the dip after Thursday’s slump amid the US government bond yields easing. On the local data front, June jobs data is set to take the spotlight while major banks in the US prepare for earnings season to start. Why Credit Suisse raises Rio Tinto’s (ASX:RIO) price target...

Read more...

ImpediMed (ASX:IPD) – early detection of lymphoedema, July 2021

08 Jul 2021 - ImpediMed Limited (ASX:IPD) CEO and Managing Director Richard Carreon discusses the company's bioimpedance spectroscopy platform SOZO, which is particularly targeted at noninvasive clinical assessment and monitoring of fluid status and tissue composition in the treatment of secondary lymphoedema, heart failure and renal failure.

Read more...